Access cutting-edge melanoma treatment through this clinical trial at a research site in Knoxville. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Knoxville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN2810, also known as cemiplimab (each individually called a "study drug" or called "study drugs" when combined). The study is focused on patients with a type of skin cancer known as melanoma. The aims of the study are to see how effective the combination of fianlimab and cemiplimab are in treating the melanoma skin cancer, in comparison with a medicati
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this melanoma clinical trial in Knoxville, TN
If you're searching for melanoma treatment options in Knoxville, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Knoxville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.